bims-pideca Biomed News
on Class IA PI3K signalling in development and cancer
Issue of 2026–07–19
fifteen papers selected by
Ralitsa Radostinova Madsen, MRC-PPU



  1. Biosci Rep. 2026 Aug 19. pii: BSR20250116. [Epub ahead of print]46(8):
      Cellular processes are controlled by interconnected networks of protein-protein interactions that can be dynamically regulated by post-translational modifications such as phosphorylation. Dysregulation of signaling pathways can drive cellular transformation and contribute to cancer treatment resistance. Mass spectrometry (MS)-based approaches have emerged as key technologies to study both protein function and their dynamic regulation at a network level. Modern proteomics allows investigators to study how signaling networks are rewired in response to genetic lesions, external cues, and targeted therapies, enabling the comparison of baseline (steady-state) networks to perturbed states. Here, we briefly describe key advancements in proteomics to study signaling dynamics, including affinity-purification combined with MS, proximity proteomics (e.g., BioID, APEX), and phosphoproteomics. We highlight how proteomics has led to the identification of comprehensive protein-protein interaction networks, to the delineation of protein subcellular localization maps and to discoveries regarding their dynamics and rewiring in disease. Finally, we comment on the future directions of proteomics to study signaling dynamics, enabled by next-generation MS instruments and AI-driven data analysis, and discuss how these developments are paving the way for clinical translation by bringing quantitative network biology into patient-relevant contexts.
    Keywords:  cancer; mass spectrometry; phoshorylation; protein dynamics; proteomics; signalling
    DOI:  https://doi.org/10.1042/BSR20250116
  2. EMBO J. 2026 Jul 11.
      Anabolic and catabolic processes are coordinated by a conserved regulatory network, which includes the nutrient-sensing protein kinase mTOR complex 1 (mTORC1) and the insulin- and stress-responsive transcription factor FoxO. In a physiological setting, these regulators align growth, storage, reproduction, and aging with nutrient availability. Here, we identify transcription factor Spalt-related (Salr), previously implicated in organogenesis, as a negative regulator of growth and lipid storage in Drosophila melanogaster. Salr activates catabolic gene expression and restricts mTORC1-mediated cell growth in the Drosophila fat body. The genomic binding of Salr overlaps extensively with that of FoxO, and a similar convergence is observed for their mammalian homologs, SALL1 and FOXO1. Both Salr and FoxO are activated upon fasting, but respond to distinct cues: while FoxO displays transient activation and is responsive to AKT inhibition, Salr is activated in a slow and sustained manner through the integrated stress response. Once activated, Salr counters nuclear localization of FoxO. Taken together, we show that Salr and FoxO are growth-inhibitory transcription factors that act in a convergent manner to respond to nutrient stress through distinct cues.
    DOI:  https://doi.org/10.1038/s44318-026-00858-1
  3. Cell Commun Signal. 2026 Jul 14.
       BACKGROUND: Genomic analysis has revealed that approximately 40% of bladder cancer (BLCA) tumors harbor alterations in the PI3K/AKT pathway, with PIK3CA mutations occurring in 15-25% of cases. PIK3CA, which encodes the catalytic p110α subunit of PI3K, plays a critical role in regulating cell survival, proliferation, and metabolism. However, the metabolic and functional consequences of PIK3CA mutations in BLCA remain poorly defined.
    METHODS: To investigate the role of PIK3CA mutations in BLCA, we performed targeted sequencing on tumors from patients, identifying recurrent alterations. Using CRISPR/Cas9 knock-in models in SCaBER and UM-UC-3 cell lines, we introduced the PIK3CA E545K mutation to study its effects. We conducted transcriptomic profiling, targeted metabolomics, and stable isotope tracing to assess metabolic reprogramming. Functional assays measured proliferation, mitochondrial complex I activity, and glutaminolysis. Orthotopic xenografts in mice were used to evaluate in vivo tumor growth and metabolism.
    RESULTS: PIK3CA mutations were present in 20% of cases, consistent with TCGA data. The E545K and E545Q hotspots accounted for 70% of these mutations. PIK3CA E545K strongly activated PI3K/AKT signaling. Transcriptomic analysis revealed enrichment of OXPHOS, fatty acid metabolism, and mTORC1 signaling. Metabolomics indicated changes in TCA cycle metabolites and enhanced reductive carboxylation of glutamine to citrate, driving fatty acid synthesis. Mutant cells showed increased expression of GLS1 and FASN, higher proliferation rates, and elevated mitochondrial complex I activity. In vivo, PIK3CA-mutant xenografts displayed significantly increased tumor growth.
    CONCLUSION: PIK3CA mutations are frequent drivers of metabolic reprogramming in BLCA, leading to increased glutamine flux, elevated OXPHOS activity, and enhanced fatty acid synthesis, all of which contribute to tumor progression. These findings provide the first comprehensive evidence that PIK3CA-driven metabolic alterations are both biomarkers of aggressive disease and actionable therapeutic targets. The efficacy of PI3Kα inhibition in combination with metabolic targets may support its potential in precision medicine for PIK3CA-mutant BLCA and highlights the value of integrating metabolic biomarkers into treatment strategies for advanced BLCA.
    DOI:  https://doi.org/10.1186/s12964-026-03058-w
  4. J Clin Invest. 2026 Jul 15. pii: e199709. [Epub ahead of print]136(14):
      Antimetabolites, chemotherapy targeting nucleotide biosynthesis, are among the oldest and most widely used cancer treatments, yet resistance remains a daunting barrier, especially in the fight against B cell lymphomas. However, the underlying mechanisms of this resistance have long remained elusive. Using an innovative, integrated omics approach, we unexpectedly identified that the accumulation of dipeptides and upregulation of the dipeptide transporter SLC15A3 underlie resistance to nucleotide deficiency in a Myc-driven large B cell lymphoma mouse model. A similar mechanism occurred after long treatment of human B cell lymphoma cells with the chemotherapeutic purine synthesis inhibitor 6-mercaptopurine (6MP). Mechanistically, we demonstrated that dipeptides containing essential amino acids activated the growth and survival mTOR complex 1 (mTORC1) signaling pathway. Notably, SLC15A3 specifically interacted with mTOR on the lysosome, boosting mTORC1 activity selectively in resistant lymphoma cells but not in parental cancer cells. Silencing SLC15A3 diminished mTORC1 activity and restored resistant lymphoma sensitivity to 6MP. Strikingly, resistant lymphomas, but not primary tumors, exhibited heightened sensitivity to the clinical mTOR inhibitor, rapamycin, in culture and in vivo. We extended these findings in human lymphoma biopsies, which revealed increased SLC15A3 expression following antimetabolite therapy. Together, our study uncovered a metabolic adaptation that fuels cancer resistance to nucleotide deficiency and positions the mTORC1 inhibitor, rapamycin, as a potential therapeutic strategy for transforming the management of chemotherapy-resistant lymphomas.
    Keywords:  Drug therapy; Hematology; Lymphomas; Metabolism; Oncology
    DOI:  https://doi.org/10.1172/JCI199709
  5. Small Methods. 2026 Jul 12. e70828
      Fluorescence resonance energy transfer (FRET) biosensors enable quantitative visualization of protein interactions and signaling dynamics in living cells. However, most fluorescent protein (FP) FRET pairs occupy overlapping spectral regions, limiting multiplexing and simultaneous imaging of multiple pathways. In particular, the limited availability of well-characterized near-infrared (NIR) acceptors has constrained robust dual-FRET measurements within single cells. Here, we characterize a red-to-NIR FP FRET pair comprising mRuby2 and miRFP670nano3. Fluorescence lifetime imaging microscopy (FLIM) demonstrates efficient energy transfer with minimal spectral bleed-through and compatibility with established CFP/YFP-based reporters. In comparison with alternative dual-FRET strategies, including dark acceptors and long Stokes shift FPs, this pair enables multiplexed imaging without extensive spectral unmixing or correction. Structural modeling suggests that favorable donor-acceptor geometry may contribute to its FRET efficiency. We demonstrate the utility of this red-to-NIR pair by simultaneous FLIM-FRET imaging of Akt and S6K activity in single cells, providing parallel readouts of distinct branches of PI3K-mTOR signaling. In three-dimensional invasion assays, dual imaging of Src and ROCK reporters reveals spatially coordinated signaling dynamics not evident in single-reporter measurements. Together, these results establish mRuby2/miRFP670nano3 as a practical addition to the FP-FRET toolbox for multiplexed interrogation of signaling networks in living cells.
    Keywords:  FLIM; FRET; biosensors; cell signaling; fluorescent proteins; mRuby2; miRFP670nano3
    DOI:  https://doi.org/10.1002/smtd.70828
  6. Bioessays. 2026 Jul;48(7): e70165
      PH domain leucine-rich repeat protein phosphatases 1 and 2 (PHLPP1/PHLPP2) have, for more than 20 years, been described as Akt phosphatases and tumor suppressor genes. Approximately 200 PubMed-indexed articles have been published on the topic, including efforts to pharmacologically inhibit PHLPP in disease settings. A recent study, however, presents evidence that PHLPP is actually a pseudophosphatase with no catalytic activity. These observations question its reported role in cancer. The designation of PHLPP1 and PHLPP2 as pseudophosphatases necessitates both a critical examination of the literature and new hypotheses for the biological function of these ancient proteins. Here, we review the emergence of PHLPP1 and PHLPP2 as cellular signal transducers, critically examine the evidence for their reported phosphatase activity and tumor suppressor functions, and propose steps to elucidate their biological functions.
    Keywords:  Akt signalling; PHLPP; Protein Kinase B; cancer; cell biology; kinase; membrane; phosphatase; phylogenetics; tumor suppressor gene
    DOI:  https://doi.org/10.1002/bies.70165
  7. Nat Commun. 2026 Jul 16.
      Reactions involving small GTPases and phosphatidylinositol phosphate (PIP) lipids serve essential roles in signal transduction at the plasma membrane. In cells, these distinct classes of molecules are linked through positive and negative feedback loops that give rise to emergent properties such as excitability and polarization. Here, we reconstitute communication and feedback between Ras GTPase and phosphatidylinositol 3-kinase gamma (PI3Kγ)-mediated PIP3 production on supported membranes using purified proteins. We employ light-induced membrane recruitment to rapidly shift steady-state conditions and observe the spatiotemporal response of the signaling module. Alone, the Ras-PI3Kγ module exhibits transient and reversible activation due to global inhibition. The introduction of GEF-mediated positive feedback enables sustained threshold crossing and local amplification of Ras(GTP) and PIP3, resulting in a traveling, bistable wave of activity with characteristics of an excitable network. Spatial coupling between Ras(GTP) and PIP3 lipids depends on lateral diffusion and feedback circuit architecture. This work illuminates the roles activation thresholds, membrane diffusion, and positive feedback play in regulating the dynamics of Ras-PI3Kγ membrane signaling reactions in the presence of global inhibition.
    DOI:  https://doi.org/10.1038/s41467-026-75652-y
  8. Arch Gynecol Obstet. 2026 Jul 14.
       PURPOSE: Ovarian clear cell carcinoma (OCCC) is frequently characterized by dysregulation of the PI3K/AKT/mTOR (PAM) pathway; however, the expression patterns and clinical significance of class I PI3K catalytic isoforms remain incompletely understood. This study aimed to comprehensively evaluate PI3K catalytic subunit expression, co-expression patterns, and their prognostic relevance in OCCC.
    METHODS: A retrospective cohort of 100 patients with OCCC was analyzed. Immunohistochemistry was performed to assess the expression of p110α, p110β, p110δ, p110γ, and pAKT. PIK3CA exon 9 and exon 20 mutations were evaluated in available formalin-fixed paraffin-embedded tissues. Associations between PI3K isoforms, pAKT activation, clinicopathological characteristics, and survival outcomes were investigated.
    RESULTS: The expression positivity rates of the four class I PI3K catalytic subunits in OCCC were 86% for p110γ, 77% for p110α, 58% for p110δ, and 56% for p110β. p110α and p110β were positively associated with pAKT activation, whereas p110δ and p110γ showed no significant association. p110δ expression was significantly correlated with PI3KCA exon9 mutation. Frequent co-expression of multiple PI3K catalytic subunits was observed, with simultaneous expression of all four isoforms representing the predominant pattern and significantly correlating with pAKT positivity. In advanced-stage disease, p110β expression was significantly associated with poorer progression-free survival (PFS), while pAKT positivity correlated with worse overall survival (OS) and PFS.
    CONCLUSIONS: OCCC displays substantial heterogeneity in PI3K catalytic isoform expression and co-expression. p110α and p110β were associated with pAKT activation. In advanced-stage OCCC, high p110β expression was associated with poorer PFS, whereas pAKT activation was associated with both poorer PFS and OS, supporting further investigation of PI3K-targeted therapeutic strategies.
    Keywords:   PIK3CA mutations; Ovarian clear cell carcinoma; PI3K subunits; Prognosis
    DOI:  https://doi.org/10.1007/s00404-026-08525-w
  9. JACC Case Rep. 2026 Jul 13. pii: S2666-0849(26)02389-2. [Epub ahead of print] 109228
       BACKGROUND: Congenital vascular malformations are an under-recognized cause of venous thromboembolism in young adults, and their early identification carries important management implications.
    CASE SUMMARY: A 23-year-old man presented with intermediate-high risk pulmonary embolism (PE) and right ventricular dysfunction in the context of lifelong unilateral lower extremity varicosities. After classification by the PE response team, catheter-directed thrombolysis with EKOS ultrasound-assisted catheters achieved hemodynamic stabilization. Subsequent magnetic resonance venography identified extensive venous malformations, embryonic lateral vein persistence, and osseous involvement of the femoral medullary cavity, establishing a diagnosis of Klippel-Trénaunay syndrome (KTS) within the PIK3CA-related overgrowth spectrum. The patient was transitioned to long-term direct oral anticoagulation and referred for genetic counseling and PIK3CA mutation testing.
    DISCUSSION: KTS, a PIK3CA-related overgrowth spectrum disorder caused by somatic PIK3CA gain-of-function mutations, confers elevated lifelong venous thromboembolism (VTE) risk because of dysmorphic venous architecture and abnormal perforator veins. Recognition of this syndrome in young patients with VTE is essential, as it directs structured long-term surveillance, individualized thromboprophylaxis, and eligibility for emerging PI3K-AKT-mTOR targeted therapies.
    TAKE-HOME MESSAGES: Young patients with unprovoked PE and unilateral, early onset varicosities warrant evaluation for congenital vascular malformations. Identifying KTS enables multidisciplinary management and long-term VTE risk reduction.
    Keywords:  Klippel-Trénaunay syndrome; PIK3CA-related overgrowth spectrum; catheter-directed thrombolysis; congenital vascular malformation; deep venous thrombosis; pulmonary embolism
    DOI:  https://doi.org/10.1016/j.jaccas.2026.109228
  10. Sci Signal. 2026 Jul 14. 19(946): eaeb7989
      Triglycerides can be formed by fatty acid esterification of glycerol 3-phosphate (G3P) and by de novo lipogenesis (DNL). We identified G3P as a stimulus that activated mTORC1, a nutrient-sensing protein complex that promotes DNL in the liver. We found that the major source of G3P in primary mouse hepatocytes was glycerol kinase (GK), which generates G3P from glycerol. Mice with a liver-specific GK deficiency showed reductions not only in hepatic triglyceride production and storage but also in mTORC1-dependent DNL. Sequentially blocking hepatic pathways for G3P metabolism and analysis of hepatocytes and mice deficient in glycerol phosphate dehydrogenases, alternative enzymatic sources for G3P, showed that mTORC1 activation positively correlated with G3P amounts and was not mediated by a G3P precursor or other glycerol metabolites. G3P generated by wild-type GK in glycerol-treated cells induced mTORC1 activation through GATOR2, a complex that also activates mTORC1 in response to amino acids. In contrast, GK with inactivating mutations found in GK deficiency did not induce activation of mTORC1 in response to glycerol. These results show that by coordinating the production of substrates needed for esterification, G3P stimulates hepatic DNL through mTORC1 activation. In obesity, higher glycerol levels and enhanced GK-mediated metabolism drive hepatic TG accumulation, contributing to metabolic dysfunction-associated fatty liver disease.
    DOI:  https://doi.org/10.1126/scisignal.aeb7989
  11. Cell Mol Life Sci. 2026 Jul 15.
      Moesin (Msn) is a member of the ERM (Ezrin, Radixin, and Moesin) protein family implicated in cell-cell recognition, cell adhesion, and migration. In this work, we identified Msn as an ανβ3 integrin-interacting molecule in human endothelial cells, with a role in endothelial cell signaling and angiogenesis. Msn and its active phosphorylated form are highly expressed in endothelial cells in vitro and in vivo. Pleiotrophin and vascular endothelial growth factor A165 (VEGFA165), increase Msn phosphorylation and decrease the interaction of Msn with ανβ3 integrin. Downregulation of Msn expression in endothelial cells using siRNA reduced VEGF receptor 2 (VEGFR2) expression and activation. It also decreased permeability, collective cell migration, and tube formation in vitro, concomitant with reduced angiogenesis and blood-brain barrier permeability in Msn knockout mice. Concurrently, it decreased β3 integrin expression, increased the c-Src- and phosphoinositide 3-kinase (PI3K)-dependent cell-surface localization of nucleolin, and activated ERK1/2 kinases and cMet. Pharmacological inhibitors of c-Src, PI3K, cell-surface nucleolin, ERK1/2, and cMet, but not of VEGFR2 or αvβ3 integrin, abolished siMsn-induced individual-cell motility. Taken together, these findings identify a novel binding partner of the αvβ3 integrin that regulates the activation of cMet and VEGFR2 in endothelial cells, clarifying the mechanisms underlying the activation of multiple angiogenic pathways and highlighting potential new targets for improving anti-angiogenic therapies.
    Keywords:  Amoeboid cell migration; Receptor recycling; Tight junctions; VE-cadherin; ZO-1
    DOI:  https://doi.org/10.1007/s00018-026-06352-5
  12. PLoS Comput Biol. 2026 Jul 13. 22(7): e1014472
      Cell migration is a fundamental biological process essential for embryonal development, immune function, and cancer metastasis, with migration velocity representing a key parameter of this behaviour. Today, cell migration velocity can be measured in high-throughput assays that generate complex, hierarchically structured datasets with technical noise, batch effects, and biological variability, introducing significant uncertainty in velocity estimates. Current statistical approaches often fail to rigorously quantify this uncertainty, limiting reproducibility and comparisons across independent experimental datasets. Here, we present cellmig, a specialized computational tool that addresses this challenge. It implements established Bayesian hierarchical modeling within an accessible workflow tailored for high-throughput live cell migration assays, to separate biological signals from technical variation while explicitly quantifying uncertainty in migration velocity. cellmig provides a robust framework for analyzing cell migration assays, including dose-response studies and large-scale screens with multiple biological and technical replicates. By modeling biological variability (e.g., compound-dependent effects) and technical confounders (e.g., batch variability) within a unified Bayesian framework, cellmig estimates condition-specific effects on cell velocity with probabilistic uncertainty intervals, avoiding common pitfalls associated with null-hypothesis testing. Through exhaustive benchmarking against commonly used approaches in the field, we demonstrate that cellmig achieves improved sensitivity in detecting subtle migration effects and enhanced robustness against technical variability. Additionally, its generative models enable simulation of migration velocities under various assumptions, aiding experimental planning. We validated cellmig through a tiered strategy: (1) benchmarking on two independent experimental datasets and (2) deployment on a large-scale high-throughput screen that discovered new chemical biology. Our results demonstrate that cellmig can detect subtle dose-dependent velocity changes, maintain robustness against systematic variability and batch effects, and facilitate reliable integration of multi-experiment datasets. In summary, cellmig enhances reproducibility, reliability, and biological insight in high-throughput migration studies, facilitating quantitative inter-dataset comparisons. cellmig is implemented as an open-source R package and is freely available on Bioconductor (https://bioconductor.org/packages/cellmig).
    DOI:  https://doi.org/10.1371/journal.pcbi.1014472
  13. Eur J Hum Genet. 2026 Jul 16.
      PTEN hamartoma tumour syndrome (PHTS) is a diverse multi-system disorder predisposing to a high hereditary risk of breast, thyroid, endometrial, and a moderate risk of renal, and colorectal cancer and skin melanoma. Besides the risk of cancer, PHTS is also associated with benign tumours such as skin and connective tissue tumours, vascular malformations and neurodevelopmental disorders, including autism spectrum disorders. New evidence on cancer risks and the effectiveness of surveillance has been published since the last iteration of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) guidelines from 2020, necessitating the update presented here A comprehensive literature review was undertaken, and guidelines were revised by clinicians with PHTS expertise from relevant medical disciplines, together with PHTS patients and their representatives. Revised recommendations were put forward for surveillance for breast, thyroid, endometrial, renal, and colorectal cancer and skin melanoma. The proposed cancer surveillance recommendations for PHTS require significant patient commitment as well as a coordinated multidisciplinary medical approach. There is a need for prospective evaluation of the effectiveness of these recommendations in the PHTS population.
    DOI:  https://doi.org/10.1038/s41431-026-02181-z
  14. Cancer Genet. 2026 Jul 01. pii: S2210-7762(26)00079-7. [Epub ahead of print]306-307 214-217
       BACKGROUND/OBJECTIVES: Kaposiform haemangioendothelioma (KHE) is a rare vascular neoplasm usually presenting in childhood. Its high morbidity and mortality is secondary to compression, invasion, and coagulopathy. The pathogenensis of KHE remains poorly understood although mTOR inhibitors have been used successfully in management. PTENHarmatoma Tumour Syndrome (PHTS) is a well characterised tumour predisposition syndrome with an ∼85% lifetime tumour risk. In addition, over 50% of patients have vascular anomalies. However, malignant vascular tumours are not a recognised association.
    CASE: A 28-year-old female with a KHE was enrolled in the IMAGINE study (Integrating Medically Actionable Genomics Into Early Phase Trials). A PTEN heterozygous c.277C>T p.(His93Tyr) pathogenic variant was detected initially in tumour tissue and subsequently saliva confirming a constitutional (germline) variant. Reverse phenotyping revealed the patient had a large head circumference, palmar keratosis and papillomas on the hand, feet, and gums, in keeping with PHTS.
    CONCLUSION: As malignant vascular neoplasms have not been well described in PHTS, this case further demonstrates the utility of genomic tumour profiling in early diagnosis of an Inherited Cancer Susceptibility Disorder (ICSD); particularly in young patients or in those where other features may be subtle. A plausible biological mechanism through upregulation of mTOR signalling also suggests malignant vascular tumours may be a rare tumour association with PHTS.
    Keywords:  Kaposiform haemagioendothelioma; PTEN; mTOR signalling
    DOI:  https://doi.org/10.1016/j.cancergen.2026.06.011
  15. Redox Biol. 2026 Jul 07. pii: S2213-2317(26)00288-0. [Epub ahead of print]95 104289
      The cytochrome P450 redox system is composed of a cytochrome P450 reductase (POR) and multiple CYP450 enzymes (CYP450). Of the CYP450 isoenzymes, CYP51A1 is essential for endogenous cholesterol biosynthesis. Elevated circulating cholesterol is a well-established risk factor for cardiovascular disease, however, the role of intracellular cholesterol synthesis in normal endothelial function remains unclear. To investigate this, we generated CRISPR/Cas9 knockouts of the cytochrome P450 reductase in primary human endothelial cells (EC) and studied an endothelial-specific, tamoxifen-inducible POR knockout mouse (ecPOR-/-). Deletion of POR led to the accumulation of lanosterol, the substrate of POR/CYP51A1, and a reduction in desmosterol. Functionally, POR deficiency promoted basal and VEGF-induced angiogenesis in spheroids and mouse aortic segments. Retinal angiogenesis was increased in ecPOR-/- mice in vivo. Mechanistically, POR deletion activated the Sterol Regulatory Element Binding Transcription Factor (SREBP2) regulatory pathway, as shown by increased nuclear translocation of cleaved SREBP2 in EC and in en face-stained mouse aortae. Overexpression of nuclear SREBP2 in endothelial cells mimicked the angiogenic phenotype observed upon POR deletion. Conversely, double deletion of POR and SREBP2 normalized angiogenesis to levels of control cells. RNAseq of POR-deficient EC revealed an upregulation of PI3K-related signaling pathways and genes involved in cholesterol homeostasis, including enhanced expression of pro-angiogenic factors. In line with these findings, knockout of POR increased cellular PIP3 levels, AKT phosphorylation, and activation of downstream targets such as p70 S6 kinase. These findings demonstrate that inhibition of the endothelial POR/CYP51A1 axis impairs endogenous cholesterol synthesis, activates SREBP2, and enhances angiogenesis via PI3K/AKT/mTOR signaling, highlighting a critical and novel link between intracellular cholesterol metabolism and vascular growth.
    Keywords:  Angiogenesis; Cholesterol; Cytochrome P450 oxidoreductase; SREBP2
    DOI:  https://doi.org/10.1016/j.redox.2026.104289